RT Journal Article
SR Electronic
T1 Urban Sprawl of Covid-19 Epidemic in India: Lessons in the First Semester
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.17.20176537
DO 10.1101/2020.08.17.20176537
A1 Rajeev Gupta
A1 Kiran Gaur
A1 Raghubir S Khedar
A1 Rajinder K Dhamija
YR 2020
UL http://medrxiv.org/content/early/2020/08/21/2020.08.17.20176537.abstract
AB Background & Objective The covid-19 epidemic is rapidly escalating in India and unlike developed countries there is no evidence of plateau or decline in the past 6 months. To evaluate association of state-level sociodemographics with incident cases and deaths we performed an ecological study.Methods Publicly available data sources were used. Absolute number of covid-19 cases and deaths were obtained and cases and deaths/million in each state calculated from February to July 2020. To assess association of state level disease burden with sociodemographic variables (urbanization, human development, healthcare availability, healthcare access and quality etc.) we determined Pearson’s correlation and logarithmic trends.Results Covid-19 in India has led to >2,000,000 cases and 45,000 deaths by end July 2020. There is large variation in state-level cases/million ranging from 7247 (Delhi), 3728 (Goa) and 3427 (Maharashtra) to less than 300/million in a few. Deaths/million range from 212 (Delhi), 122 (Maharashtra) and 51 (Tamilnadu) to 2 in north-eastern states. Most of the high burden states (except Delhi) are reporting increasing burden and deaths with the largest increase in July 2020. There is a significant positive correlation of urbanization with covid-19 cases (r=0.65, R2=0.35) and deaths (r=0.60, R2=0.28) and weaker correlation with other sociodemographic variables. From March to July 2020, stable R2 value for urbanization is observed with cases (0.37 to 0.39) while it is increasing for deaths (0.10 to 0.28).Conclusions Covid-19 epidemic is escalating in India and cases as well as deaths are significantly greater in more urbanized states. Prevention, control and treatment should focus on urban health systems.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding available.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Eternal Heart Care Centre and Research Institute, Jaipur, India, IRB Registration number ECR/615/Inst/RJ/2014/RR-20All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThere are no data other than submitted in the manuscript. http://www.covid19india.org